ArticleCancers2023

Retreatment with Cisplatin May Provide a Survival Advantage for Children with Relapsed/Refractory Hepatoblastoma: An Institutional Experience.

Katherine M Somers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.